Literature DB >> 30710604

The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review: Etiology and clinical work-up.

Shiri Nawrocki1, Jisun Cha2.   

Abstract

Hyperhidrosis (HH) is a dermatologic disorder defined by sweat production exceeding thermoregulatory needs. Clinically, HH is diagnosed when excess sweating creates significant emotional, physical, or social discomfort, causing a negative impact on the patient's quality of life. Existing data imply that this condition may affect at least 4.8% of the US population. The etiology of HH may stem from a complex autonomic nervous system dysfunction, resulting in neurogenic overactivity of otherwise normal eccrine sweat glands. Alternatively, HH may be a result of aberrant central control of emotions. This condition is categorized as primary or secondary HH. Approximately 93% of patients with HH have primary HH, of whom >90% have a typical focal and bilateral distribution affecting the axillae, palms, soles, and craniofacial areas. Secondary HH presents in a more generalized and asymmetric distribution and is generated by various underlying diseases or medications. Secondary causes of HH need to be excluded before diagnosing primary HH.
Copyright © 2019 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  apocrine sweat gland; apoeccrine sweat gland; autonomic nervous system; axillary sweating; eccrine sweat gland; emotional sweating; excessive sweating; facial sweating; hyperhidrosis; oversweating; palmar sweating; plantar sweating; primary hyperhidrosis; secondary hyperhidrosis; sweat overproduction; thermoregulatory sweating

Mesh:

Substances:

Year:  2019        PMID: 30710604     DOI: 10.1016/j.jaad.2018.12.071

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  17 in total

1.  The efficacy and safety of a fractional microneedle radiofrequency device for the treatment of axillary hyperhidrosis: clinical prospective pilot study.

Authors:  Joon Min Jung; Hyoung Min Na; Jung Ho Kim; Jihae Yoon; Hee Joo Yang; Woo Jin Lee; Sung Eun Chang; Mi Woo Lee; Chong Hyun Won
Journal:  Lasers Med Sci       Date:  2021-08-28       Impact factor: 3.161

2.  Microneedling Delivery of Botulinum Toxin Versus Intradermal Injection in the Treatment of Facial Hyperhidrosis.

Authors:  Howyda Ebrahim; Amany Nassar; Mariam Mohammed Mousa; Elsayed Khater
Journal:  J Clin Aesthet Dermatol       Date:  2022-09

3.  Hyperhidrosis Comorbidities and Treatments: A Register-based Study among 511 Subjects.

Authors:  Sanna-Liisa Heiskanen; Jani Niskala; Jari Jokelainen; Kaisa Tasanen; Laura Huilaja; Suvi-Päivikki Sinikumpu
Journal:  Acta Derm Venereol       Date:  2022-02-28       Impact factor: 3.875

4.  Pharmacologic Mydriasis Secondary to Topical Glycopyrronium Tosylate Cloths: Clinical Characterization From a Multicenter Analysis.

Authors:  Aaron R Kaufman; Shawn Gulati; John H Pula; Timothy M Janetos; Neena R Cherayil; Eric Chiu; Emily Anne Shepherd; Karl C Golnik; Enrique Garcia-Valenzuela; Peter W MacIntosh; Brooke T Johnson; Kimberlee M Curnyn
Journal:  J Neuroophthalmol       Date:  2022-03-24       Impact factor: 4.415

5.  Management Strategies Of Palmar Hyperhidrosis: Challenges And Solutions.

Authors:  Stamatios Gregoriou; Polytimi Sidiropoulou; Georgios Kontochristopoulos; Dimitrios Rigopoulos
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-04

6.  New sympathicotomy for prevention of severe compensatory hyperhidrosis in patients with primary hyperhidrosis.

Authors:  Jung Wook Han; Jae Jun Kim; Yong Hwan Kim; In Sub Kim; Seong Cheol Jeong
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 2.895

7.  Hyperhidrosis, Endoscopic Thoracic Sympathectomy, and Cardiovascular Outcomes: A Cohort Study Based on the Korean Health Insurance Review and Assessment Service Database.

Authors:  Jae-Min Park; Duk Hwan Moon; Hye Sun Lee; Ju-Young Park; Ji-Won Lee; Sungsoo Lee
Journal:  Int J Environ Res Public Health       Date:  2019-10-15       Impact factor: 3.390

8.  Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis.

Authors:  Lindsay McCormack; Joseph Ponce; Avik Chatterjee; Jennifer K Tan
Journal:  JAAD Case Rep       Date:  2021-01-11

9.  Effects of lower thoracic sympathicotomy on plantar hyperhidrosis.

Authors:  Seong Cheol Jeong; Jae Jun Kim; In Sub Kim; Yong Hwan Kim; Jung Wook Han; Seok Whan Moon
Journal:  J Thorac Dis       Date:  2021-02       Impact factor: 2.895

10.  Thoracic sympathectomy for the treatment of primary axillary hyperhidrosis: systematic review and proportional meta-analysis.

Authors:  Gilmar Felisberto; Antônio José Maria Cataneo; Daniele Cristina Cataneo
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.